Effect of Long-term Ketogenic Diet on Serum Alanine Transaminase Levels in Mice (Mus musculus)
Miftahussurur M., Fasitasari M., Rejeki P.S., Meiliana I.D.
Abstract
The prevalence of obesity is increasing worldwide over the years. One of the non-pharmacological therapy which is believed to be promote weight loss is ketogenic diet. Nevertheless, the long-term effects which may be caused by this diet are still debating, especially in the liver. This study aimed to determine the effect of long-term ketogenic diet (8 weeks) on serum alanine transaminase (ALT) levels. Twelve male mice were divided into basal diet (BD) and ketogenic diet (KD) group and given intervention for eight weeks adlibitum. Body weight was weighed in pre and post-intervention, while ALT levels were measured only once after eight weeks of intervention. As a result, pre-intervention body weight in the BD group was 25.170 ± 2.858 g and KD group was 27.170 ± 1.329 g (P =0.151). In the post-intervention, body weight in BD and KD group were 44.500 ± 5.244 g and 31.830 ± 5.707 g, respectively (P =0.003). BD group showed a significant difference between pre-and post-intervention body weight (P <0.0001); however, it was not significant in the KD group (P =0.096). After eight weeks, serum ALT levels in BD-fed mice were 90.672 ± 20.786 U/L and in KD-fed mice showed 117.037 ± 19.261 U/L (P =0.046). In conclusion, KD elevated serum ALT levels and attenuated weight gain after 8-week KD supplementation.
Long-term ketogenic diet contributes to glycemic control but promotes lipid accumulation and hepatic steatosis in type 2 diabetic mice
Du B., Gan Y., Lan R., Qian M., Qin J., Ren H., Shi J., Zhang X., Zhao Y., Zhu B.
Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease
Chen C., Chen S., He F., Karin M., Knight R., Tripathi A., Tukey R.H., Vu C., Yueh M.-F.
Fibroblast Growth Factor 21 as an emerging metabolic regulator: Clinical perspectives
Lam K.S.L., Wang Y., Woo Y.C., Xu A.
A long-term ketogenic diet decreases serum insulin-like growth factor-1 levels in mice
Prabowo G.I., Rejeki P.S., Widiatmaja D.M.
No Title
Ketogenic diet in cancer therapy
Aminazdeh-Gohari S., Kofler B., Weber D.D., Aminazdeh-Gohari S., Kofler B., Weber D.D.
The role of liver fructose-1,6-bisphosphatase in regulating appetite and adiposity
Andrikopoulos S., Fam B.C., Favaloro J.M., Joannides C.N., Khalid N.F.I., Lamont B.J., Proietto J., Shulkes A., Tiganis T., Visinoni S., Whitehead J., Yim M.
Ketogenic diet slows down weight gain in juvenile Mus musculus with benzopyrene as cancer inducer
Al-Arif M.A., Herawati L., I'tishom R., Miftahussurur M., Rejeki P.S., Utami D.M.
Ketogenic diet and epilepsy
Czuczwar S.J., Januszewski S., Pluta R., Ulamek-Koziol M., Ulamek-Koziol M.
Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease
Allison M.A., Barter P.J., Budoff M.J., McClelland R.L., Ong K.L., Rye K.-A., Tucker B., Wu B.J.
